CD120b (TNF-RII) Antibody, anti-human, REAfinity™
Synonyms: TNFRSF1B, TBPII, TNFR-II, TNF-R75, Tnfbr, TNFR1B, TNFR2, TNFR80, p75, p75TNFR
RECOMBINANT EXTENDED VALIDATION
Bioz Star93/100 Bioz rating
11 Citations5 Images
Clone:
REA520 | hTNFR-M1
Type of antibody:
Recombinant antibodies, Primary antibodies
Isotype:
recombinant human IgG1
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for CD120b (TNF-RII) Antibody, anti-human, REAfinity™

Flow cytometry applications
PE
Vio Bright FITC
Vio R667
Recommended dilution:
1:50
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
PE
Used products:
130-123-778, 130-124-000
Description:
Human peripheral blood cells after erythrocyte lysis were stained with CD120b (TNF-RII) antibodies or with the corresponding REA Control (S) antibodies (left images) and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.

Application imageView details view details

Application imageView details view details
Extended validation for CD120b (TNF-RII) Antibody, anti-human, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA520
3G7A02
high
TR75-54
low

Cells were incubated with an excess of purified unconjugated CD120b (TNF-RII) (REA520) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Sensitivity
Performance comparison

Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.

Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image

Flow cytometric comparison of different clones for CD120b (TNF-RII). Human peripheral blood mononuclear cells (PBMCs) were first stained with Viobility™ Fixable Dye followed by a suitable counterstaining. Cells were then fixed and permeabilized using the Transcription Factor Staining Buffer Set followed by intracellular staining with CD120b (TNF-RII) antibodies. As a control, CD120b (TNF-RII) antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and Viobility 405/520 Fixable Dye fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.

Specifications for CD120b (TNF-RII) Antibody, anti-human, REAfinity™
Overview

Clone REA520 recognizes the extracellular part of the membrane-bound form of the human CD120b antigen, a 75 kDa single-pass type I membrane protein, which is also known as tumor necrosis factor receptor type II (TNF-RII). CD120b is a receptor with high affinity for the cytokine tumor necrosis factor (TNF-α) and for lymphotoxin-alpha (LT-α). It belongs to the TNF receptor superfamily and is largely confined to cells of the immune system. CD120b is strongly expressed on stimulated T and B lymphocytes and on a variety of cells at low levels. Sustained activation of TNF signaling has been implicated in the pathogenesis of a wide spectrum of diseases, including cancer, osteoporosis, sepsis, diabetes, and autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease.

Additional information: Clone REA520 displays negligible binding to Fc receptors.

Alternative names

TNFRSF1B, TBPII, TNFR-II, TNF-R75, Tnfbr, TNFR1B, TNFR2, TNFR80, p75, p75TNFR

Detailed product information

Technical specifications

Clone
REA520
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (S), human IgG1
Host
human cell line
Type of antibody
Recombinant antibodies, Primary antibodies
Species reactivity
human
Antigen
CD120b (TNF-RII)
Molecular mass of antigen [kDa]
46, refers to canonical form
Distribution of antigen
B cells, T cells, lymphocytes, monocytes, macrophages, granulocytes, dendritic cells, endothelial cells, leukocytes, myeloid leukemia cells, NK cells, thymocytes, hematopoietic stem and progenitor cells, T helper cells, NKT cells, cardiac muscle
Entrez Gene ID
RRID
AB_2904703, AB_2904702, AB_2751836

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for CD120b (TNF-RII) Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?